UBE2Q2P11

Across TCGA pan-cancer cohorts, UBE2Q2P11 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated UBE2Q2P11 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher UBE2Q2P11 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated UBE2Q2P11 expression acts as an unfavorable survival marker, although some lineages such as UCS and OV show a favorable association.

THCA, STAD, and UCS are the cancer types where UBE2Q2P11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	II,III,IV	0.347	0.751	<.001	126	view →
STAD	OS	Quartile	II,III,IV	0.549	0.715	<.001	72	view →
UCS	DFS	Tertile	III,IV	1.000	0.325	.003	66	view →
TGCT	OS	Tertile	II,III,IV	0.501	0.996	<.001	54	view →
KIRC	DFS	Tertile	III,IV	0.410	0.672	.007	48	view →
COAD	OS	Tertile	III,IV	0.374	0.792	.002	45	view →
OV	OS	Tertile	II,III,IV	0.760	0.666	.010	36	view →
PCPG	DFS	Quartile	All	0.311	0.872	<.001	34	view →
LIHC	DFS	Tertile	III,IV	0.169	0.372	.049	9	view →
SKCM	OS	Tertile	II,III,IV	0.890	0.822	.037	5	view →
HNSC	OS	Tertile	All	0.780	0.565	.041	3	view →
ESCA	DFS	Median	All	0.617	0.475	.032	1	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

UBE2Q2P11–THCA (DFS)

Open the THCA breakdown →